AOD-9604 Explained: The Failed Obesity Peptide That Refuses to Die
AOD-9604 is the textbook case of a peptide that failed its pivotal weight-loss trial more than a decade ago and still gets sold to consumers — partly because Australia briefly reclassified it as a supplement, partly because compounding pharmacies in the GLP-1 shortage era picked it back up. The compound originated at Monash University in […]
AOD-9604 Explained: The Failed Obesity Peptide That Refuses to Die Read More »









